🇺🇸
United States · US · US:37662-0725_e3281609-460b-4982-e053-2995a90a01c5
Divalproex Sodium
In shortageUNIISPLATC N03AG01
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerHahnemann Laboratories, INC.
CountryUS (United States)
ATC codeN03AG01
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 3
- ndc113766207251200 PELLET in 1 VIAL, GLASS (37662-0725-1)
- ndc1137662072521200 PELLET in 1 BOTTLE, GLASS (37662-0725-2)
- ndc1137662072534000 PELLET in 1 BOTTLE, GLASS (37662-0725-3)
Annotations
UNII (FDA Substance ID)
5VOM6GYJ0D
VALPROATE SODIUM
RxCUI 9919
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Valproate Sodium Injection
Raw payload (JSON)
{
"unii": {
"unii": "5VOM6GYJ0D",
"rxcui": "9919",
"inchikey": "AEQFSUDEHCCHBT-UHFFFAOYSA-M",
"display_name": "VALPROATE SODIUM",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"773a289b-65ed-4045-80c5-f00e28c1c079": {
"match": "brand_token",
"title": "DIVALPROEX SODIUM CAPSULE, COATED PELLETS [AJANTA PHARMA USA INC.]",
"spl_version": "14",
"published_date": "2026-06-01"
}
},
"productid": "37662-0725_e3281609-460b-4982-e053-2995a90a01c5",
"productndc": "37662-0725",
"dosage_form": "PELLET",
"dea_schedule": null,
"product_type": "HUMAN OTC DRUG",
"substance_name": "VALPROATE SODIUM",
"shortage_reason": "Valproate Sodium Injection",
"shortage_status": "current",
"proprietary_name": "Divalproex Sodium",
"active_ingred_unit": "[hp_C]/1",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC",
"nonproprietary_name": "Divalproex Sodium",
"start_marketing_date": "20220706",
"active_numerator_strength": "6"
}Related drugs
Other records sharing ATC code N03AG01.
Access this data programmatically
Query Divalproex Sodium and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.